StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 17, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Sinovac Biotech's EV/EBITDA was 7.2× on Jan 29, 2021, against 7.2× a year earlier. Over the last 5 years it ranged from 6.5× to 895.3×, with a median of 8.0×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2021Jan 29, 20217.2×+0.0
2020Dec 31, 20207.2×+0.0
2019Dec 31, 20197.2×+0.0
2018Dec 31, 20187.2×−844.0
2017Dec 29, 2017851.2×+768.1
2016Dec 30, 201683.1×−71.8
2015Dec 31, 2015154.9×+133.2
2014Dec 31, 201421.6×+8.8
2013Feb 28, 201312.9×+2.7
2012Dec 31, 201210.1×+6.4
2011Feb 28, 20113.7×+1.0
2010Dec 31, 20102.7×–

More Sinovac Biotech figures

See a number that looks wrong?